KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 109 filers reported holding KALA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 3.37 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $15,000 | -21.1% | 73,144 | +16.4% | 0.00% | – |
| Q2 2022 | $19,000 | -24.0% | 62,820 | +245.2% | 0.00% | – |
| Q1 2022 | $25,000 | -40.5% | 18,200 | -47.6% | 0.00% | – |
| Q4 2021 | $42,000 | +68.0% | 34,721 | +260.0% | 0.00% | – |
| Q3 2021 | $25,000 | -98.6% | 9,645 | -97.2% | 0.00% | -100.0% |
| Q2 2021 | $1,828,000 | +373.6% | 345,071 | +502.9% | 0.00% | – |
| Q1 2021 | $386,000 | +865.0% | 57,239 | +851.1% | 0.00% | – |
| Q4 2020 | $40,000 | +122.2% | 6,018 | +150.8% | 0.00% | – |
| Q3 2020 | $18,000 | -87.5% | 2,400 | -82.4% | 0.00% | – |
| Q2 2020 | $144,000 | -0.7% | 13,663 | -17.3% | 0.00% | – |
| Q1 2020 | $145,000 | +21.8% | 16,512 | -48.7% | 0.00% | – |
| Q4 2019 | $119,000 | +124.5% | 32,163 | +130.7% | 0.00% | – |
| Q3 2019 | $53,000 | +71.0% | 13,944 | +184.6% | 0.00% | – |
| Q2 2019 | $31,000 | +93.8% | 4,900 | +157.9% | 0.00% | – |
| Q1 2019 | $16,000 | -15.8% | 1,900 | -49.8% | 0.00% | – |
| Q4 2018 | $19,000 | +280.0% | 3,786 | +657.2% | 0.00% | – |
| Q3 2018 | $5,000 | -28.6% | 500 | 0.0% | 0.00% | – |
| Q2 2018 | $7,000 | -66.7% | 500 | -61.4% | 0.00% | – |
| Q1 2018 | $21,000 | -61.1% | 1,294 | -44.9% | 0.00% | – |
| Q3 2017 | $54,000 | – | 2,350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,142,360 | $7,745,000 | 4.83% |
| RA Capital Management | 10,874,613 | $73,730,000 | 1.03% |
| Mesirow Financial Investment Management, Inc. | 43,431 | $294,462,000 | 0.93% |
| Parkman Healthcare Partners LLC | 272,445 | $1,847,000 | 0.47% |
| Samsara BioCapital, LLC | 601,162 | $4,076,000 | 0.41% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 102,198 | $693,000 | 0.40% |
| Eventide Asset Management | 3,450,000 | $23,391,000 | 0.36% |
| Orbimed Advisors | 5,465,030 | $37,053,000 | 0.32% |
| Vivo Capital, LLC | 786,883 | $5,335,000 | 0.24% |
| Knights of Columbus Asset Advisors LLC | 169,429 | $1,149,000 | 0.12% |